20 articles
Comprehensive review reveals TPE could shift from reactive treatment to preventative therapy for cardiovascular, metabolic, and neurological aging.
Randomized trial finds therapeutic plasma exchange improves lab values but doesn't reduce 30-day mortality in acute liver failure patients.
Comprehensive review reveals therapeutic plasma exchange may improve survival and organ function in sepsis patients through multiple mechanisms.
First controlled study shows therapeutic plasma exchange safely reduces biological age markers across multiple molecular pathways.
Multi-center study reveals therapeutic plasma exchange may improve survival in severe amatoxin poisoning cases.
Therapeutic plasma exchange successfully reduced soluble mesothelin levels by 44%, potentially restoring cancer drug effectiveness.
Circulate Health brings its therapeutic plasma exchange protocol to the UK via a partnership with London's Reborne longevity clinic.
Therapeutic plasma exchange emerges as potential treatment for severe postural tachycardia syndrome with autoimmune features.
Meta-analysis of 5,336 patients shows therapeutic plasma exchange significantly improves survival in acute-on-chronic liver failure.
A meta-analysis of 475 attacks finds therapeutic plasma exchange delivers high response rates in MOGAD, a rare autoimmune brain disease.
A first-of-its-kind trial shows therapeutic plasma exchange plus IVIG reduced biological age by an average of 2.6 years, confirmed by multi-omics analysis.
Comprehensive review explores plasmapheresis techniques for removing harmful blood components and potential therapeutic benefits.
A 2025 JAMA review breaks down how plasma exchange, rituximab, and caplacizumab transformed survival in this rare blood-clotting emergency.
Lymphoplasmapheresis reduces ICU time and ventilator dependence compared to standard plasma exchange in severe myasthenia gravis episodes.
Biohacker Ben Greenfield shares his three-day regenerative therapy journey including young plasma replacement and multiple longevity protocols.
Biohacker Ben Greenfield undergoes plasma exchange with young donor blood plus five other cutting-edge longevity treatments.
Biohacker Ben Greenfield documents his three-day regenerative medicine experience including young plasma exchange and advanced longevity protocols.
Updated guidelines for anti-GBM disease show how plasma exchange plus immunosuppression dramatically improves survival rates.
Dr. Khanh Nguyen reveals cutting-edge plasma exchange therapies and stem cell protocols only available in Texas.
French study reveals antibody trajectory patterns that could guide treatment decisions in thrombotic thrombocytopenic purpura.
